SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Agenus (AGEN)

AGEN RSS Feed
Add AGEN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/22/2017 3:16:48 PM - Followers: 75 - Board type: Free - Posts Today: 0

http://www.agenusbio.com/

http://finance.yahoo.com/q/ks?s=AGEN+Key+Statistics

Agenus Inc., a biotechnology company, develops and commercializes immunotherapies for cancer and infectious diseases. It markets Oncophage vaccine for the treatment of adjuvant renal cell carcinoma (kidney cancer). The company also has various product candidates under development, which include QS-21 Stimulon adjuvant, which is in Phase III clinical trials for the treatment of non-small cell lung cancer, melanoma, malaria, and singles, as well as in Phase II clinical trials for the treatment of Alzheimer's disease. In addition, the company's product candidates under development comprise Prophage, which is in Phase II clinical trials for the treatment of glioma (brain cancer) and pediatric neurological tumors; and HerpV, which is in Phase I clinical trials for the treatment of genital herpes. Further, it has various other undisclosed vaccines in Phase I and II studies. The company was formerly known as Antigenics Inc. and changed its name in January, 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.




SureTrader
Interactive Brokers Advertisement
AGEN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AGEN News: FDA Approves GSK's Shingles Vaccine with Agenus' QS-21 Stimulon® Adjuvant 10/20/2017 07:00:00 PM
AGEN News: Securities Registration Statement (simplified Form) (s-3) 10/18/2017 05:29:47 PM
AGEN News: GSK's Shingrix Containing Agenus' QS-21 Stimulon® Adjuvant Receives Marketing Authorization from Health Canada 10/13/2017 02:09:00 PM
AGEN News: Statement of Changes in Beneficial Ownership (4) 10/04/2017 05:35:05 PM
AGEN News: Statement of Changes in Beneficial Ownership (4) 10/04/2017 05:30:18 PM
PostSubject
#922   Its Approved! Ares_The_Investor 10/22/17 03:16:48 PM
#921   Will do some DD on your stocks when lakingsphan0427 10/19/17 09:37:16 PM
#920   Thanks again! H2R 10/19/17 09:13:17 PM
#919   Hey lakingsphan0427, H2R 10/19/17 07:36:43 PM
#918   Yes AGEN recovered nicely but I think its lakingsphan0427 10/19/17 06:16:59 PM
#917   By the way, AGEN PPS started with a H2R 10/19/17 05:58:41 PM
#916   Thanks for the heads up, H2R 10/19/17 05:54:41 PM
#915   Oh boy dilution! didn't see this coming.. lakingsphan0427 10/19/17 11:19:51 AM
#914   This is why AGEN is a mover lakingsphan0427 10/16/17 10:06:40 AM
#913   Shingrix: FDA decision in the coming weeks H2R 10/13/17 03:27:48 PM
#912   Shingrix (with AGEN Adjuvant): Health Canada Marketing Authorization H2R 10/13/17 03:26:20 PM
#911   Close at $ 4.74 with 3.95% of today.. lakingsphan0427 10/10/17 04:08:41 PM
#910   Sleeping giant.. lakingsphan0427 10/10/17 01:44:01 PM
#909   Good luck to you too. H2R 10/09/17 10:54:42 PM
#908   Took my initial position today now will wait lakingsphan0427 10/09/17 06:31:53 PM
#907   Flying today... Feels like some imminent news has H2R 10/02/17 12:47:42 PM
#906   http://nakedshortreport.com/index.php?index=ADXS lorema 09/13/17 03:12:46 PM
#905   Especially given today's BO of KITE by GILD. H2R 08/28/17 09:06:40 PM
#904   Hopefully investors can get over another company's failure Three2001 08/28/17 07:48:51 PM
#903   JM Cuillerot, Aug. 31, at http://www.immuno-oncologysummit.com/Personalized-Canc H2R 08/28/17 07:03:09 PM
#902   Should have halted the skid at least in Three2001 08/12/17 11:46:41 PM
#901   New in house employee handling IR for shareholders. michael johnson 07/29/17 08:35:08 AM
#900   Wow, wiped out 2 weeks worth on gains Three2001 07/27/17 07:38:48 PM
#899   * * $AGEN Video Chart 07-27-17 * * ClayTrader 07/27/17 05:33:00 PM
#898   AGEN getting noticed, mentioned in a few other Three2001 07/09/17 07:33:21 PM
#897   Interesting PPS action today: What's cooking? H2R 06/20/17 02:52:14 PM
#896   sell AGEN and buy EGBB ? trial failed biotech2 02/23/17 06:55:31 PM
#895   Trials Of Agenus Inc (NASDAQ:AGEN) Cancer Vaccine Ends trendmkr 02/23/17 02:18:27 PM
#894   AGEN rGBM Ph II: Futility H2R 02/22/17 08:49:46 AM
#893   A view on cash: H2R 02/15/17 11:17:44 AM
#892   Incyte and Agenus Amend Collaboration Agreement H2R 02/14/17 10:30:21 AM
#891   We finally got our good news. Deep tman00 02/14/17 08:04:14 AM
#890   Looking to gap up on Monday. Have a reconranger 11/11/16 04:01:39 PM
#889   High of day break coming-reconranger reconranger 11/11/16 12:19:06 PM
#888   AGEN bullish 7.23 stocktrademan 10/10/16 05:11:46 PM
#886   http://www.thefoundersdaily.com/agenus-agen-receives-price-target/662647/ crazytrader 09/02/16 12:48:17 PM
#884   http://www.newsoracle.com/2016/08/30/recent-analysts-ratings-agenus-inc-nasdaqag crazytrader 08/31/16 03:21:42 PM
#881   Gave up on Y! quite awhile ago. ID north40000 08/30/16 03:26:55 PM
#880   Agen - QS 21 Stimulon adjuvant (shingles) crazytrader 08/30/16 03:12:45 PM
#879   http://www.fool.com/investing/2016/08/18/2-cancer-therapy-stocks-that-are-ridicu crazytrader 08/30/16 03:07:16 PM
#878   http://voiceregistrar.com/2016/08/30/time-to-put-on-the-watch-list-agenus-inc-na crazytrader 08/30/16 03:02:52 PM
#877   Thanks North. The Yahoo board is crap crazytrader 08/30/16 03:00:01 PM
#876   Berlin conference in September: north40000 08/30/16 10:44:05 AM
#875   THANK YOU AGEN mick 06/09/16 05:38:16 PM
#874   i tried to use link getting ads stuff/ agen stocktrademan 06/09/16 05:30:13 PM
#873   i tried to use link getting ads stuff/ agen mick 06/09/16 04:54:42 PM
#872   Eligible to receive $100M with a $368.62M Market Cap! H2R 06/09/16 01:53:55 PM
#871   Lead Product Candidate Selection in its Collaboration with Merck H2R 06/09/16 01:22:14 PM
#870   Agenus Announces Participation In Three Oncology Conferences http://marketexclu nyctraydr 03/31/16 10:16:25 AM
#869   I've been thinking about getting back in can ed2000 03/16/16 12:56:33 PM
PostSubject